Allegretti AS, et al. - Researchers assessed Angiopoietin-2 to forecast clinical outcomes considering the prominence of vascular destabilization in decompensated cirrhosis by analyzing data of 191 inpatients. In a prospective cohort of hospitalized patients with decompensated cirrhosis and acute kidney injury, serum Angiopoietin-2 was measured serially. They studied clinical characteristics and outcomes over a 90-day period and analyzed according to Angiopoietin-2 levels. In a cohort of decompensated cirrhotic patients with acute kidney injury, Angiopoietin-2 was correlated with mortality and other clinically relevant outcomes.